Mon panier

LIF R

LIF R Informations sur la molécule

Nom anglaisLeukemia inhibitory factor receptorNombre de médicaments commercialisés0
Nombre de médicaments cliniques2Alias de la cibleLIF receptor,LIF-R,CD118
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisLeukemia inhibitory factor receptor
Alias de la cibleLIF receptor,LIF-R,CD118
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques2
Phase de R&D la plus avancéePhase 2 Clinical

LIF R Liste de produits

  • Attribut

    Protein (1)

  • Bibliothèque de produits

    En ligne (1)

  • Espèces

    Human (1)

  • Étiquette

    Fc Tag (1)

  • Marqueur

    Unconjugated (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
LIR-H4252
Human
HEK293
Human LIF R / CD118 Protein, Fc Tag
Ajouter au panier
Quantité totale1
  • 1

LIF RContexte de la molécule

Leukemia inhibitory factor receptor is also known as LIFR; CD118; FLJ98106; FLJ99923; LIF-R; SJS2; STWS; SWS, is the receptor for leukemia inhibitory factor (LIF). The leukemia inhibitory factor is a polyfunctional cytokine that affects the differentiation, survival, and proliferation of a wide variety of cells in the adult and the embryo. LIF action appears to be mediated through a high-affinity receptor complex composed of a low-affinity LIF binding chain (LIF receptor) and a high-affinity converter subunit, gp130. Both LIFR and gp130 are members of a family of cytokine receptors that includes components of the receptors for the majority of hematopoietic cytokines and for cytokines that affect other systems, including the ciliary neurotrophic factor, growth hormone and prolactin Defects in LIFR are the cause of Stueve-Wiedemann syndrome (SWS), a severe autosomal recessive condition and belongs to the group of the bent-bone dysplasias.

LIF RAlias de la molécule

LIFR,CD118,FLJ98106,FLJ99923,SJS2,STWS,SWS

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Cardiotrophin-1 (Digna Biotech/Biotecnol)CT-1Phase 2 ClinicalBiotecnol Sa, Digna Biotech Sl, Genentech IncAcute Kidney Injury; Ischemia; Liver Failure; Myocardial Reperfusion Injury
Details
MSC-1 (Northern Biologics)Phase 1 ClinicalMosaic BiosciencesCarcinoma, Non-Small-Cell Lung; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques